OBJECTIVES: We tested a circumferential mechanical dyssynchrony index (circumferential uniformity ratio estimate [CURE]; 0 to 1, 1 = synchrony) derived from magnetic resonance-myocardial tagging (MR-MT) for predicting clinical function class improvement following cardiac resynchronization therapy (CRT). BACKGROUND: There remains a significant nonresponse rate to CRT. MR-MT provides high quality mechanical activation data throughout the heart, and delayed enhancement cardiac magnetic resonance (DE-CMR) offers precise characterization of myocardial scar. METHODS: MR-MT was performed in 2 cohorts of heart failure patients with: 1) a CRT heart failure cohort (n = 20; left ventricular ejection fraction of 0.23 +/- 0.057) to evaluate the role of MR-MT and DE-CMR prior to CRT; and 2) a multimodality cohort (n = 27; ejection fraction of 0.20 +/- 0.066) to compare MR-MT and tissue Doppler imaging septal-lateral delay for assessment of mechanical dyssynchrony. MR-MT was also performed in 9 healthy control subjects. RESULTS: MR-MT showed that control subjects had highly synchronous contraction (CURE 0.96 +/- 0.01), but tissue Doppler imaging indicated dyssynchrony in 44%. Using a cutoff of <0.75 for CURE based on receiver-operator characteristic analysis (area under the curve: 0.889), 56% of patients tested positive for mechanical dyssynchrony, and the MR-MT CURE predicted improved function class with 90% accuracy (positive and predictive values: 87%, 100%); adding DE-CMR (% total scar <15%) data improved accuracy further to 95% (positive and negative predictive values: 93%, 100%). The correlation between CURE and QRS duration was modest in all cardiomyopathy subjects (r = 0.58, p < 0.001). The multimodality cohort showed a 30% discordance rate between CURE and tissue Doppler imaging septal-lateral delay. CONCLUSIONS: The MR-MT assessment of circumferential mechanical dyssynchrony predicts improvement in function class after CRT. The addition of scar imaging by DE-CMR further improves this predictive value.
OBJECTIVES: We tested a circumferential mechanical dyssynchrony index (circumferential uniformity ratio estimate [CURE]; 0 to 1, 1 = synchrony) derived from magnetic resonance-myocardial tagging (MR-MT) for predicting clinical function class improvement following cardiac resynchronization therapy (CRT). BACKGROUND: There remains a significant nonresponse rate to CRT. MR-MT provides high quality mechanical activation data throughout the heart, and delayed enhancement cardiac magnetic resonance (DE-CMR) offers precise characterization of myocardial scar. METHODS: MR-MT was performed in 2 cohorts of heart failurepatients with: 1) a CRT heart failure cohort (n = 20; left ventricular ejection fraction of 0.23 +/- 0.057) to evaluate the role of MR-MT and DE-CMR prior to CRT; and 2) a multimodality cohort (n = 27; ejection fraction of 0.20 +/- 0.066) to compare MR-MT and tissue Doppler imaging septal-lateral delay for assessment of mechanical dyssynchrony. MR-MT was also performed in 9 healthy control subjects. RESULTS: MR-MT showed that control subjects had highly synchronous contraction (CURE 0.96 +/- 0.01), but tissue Doppler imaging indicated dyssynchrony in 44%. Using a cutoff of <0.75 for CURE based on receiver-operator characteristic analysis (area under the curve: 0.889), 56% of patients tested positive for mechanical dyssynchrony, and the MR-MT CURE predicted improved function class with 90% accuracy (positive and predictive values: 87%, 100%); adding DE-CMR (% total scar <15%) data improved accuracy further to 95% (positive and negative predictive values: 93%, 100%). The correlation between CURE and QRS duration was modest in all cardiomyopathy subjects (r = 0.58, p < 0.001). The multimodality cohort showed a 30% discordance rate between CURE and tissue Doppler imaging septal-lateral delay. CONCLUSIONS: The MR-MT assessment of circumferential mechanical dyssynchrony predicts improvement in function class after CRT. The addition of scar imaging by DE-CMR further improves this predictive value.
Authors: James A White; Raymond Yee; Xiaping Yuan; Andrew Krahn; Allan Skanes; Michele Parker; George Klein; Maria Drangova Journal: J Am Coll Cardiol Date: 2006-10-31 Impact factor: 24.094
Authors: Gabe B Bleeker; Martin J Schalij; Eric Boersma; Eduard R Holman; Paul Steendijk; Ernst E van der Wall; Jeroen J Bax Journal: Am J Cardiol Date: 2006-11-09 Impact factor: 2.778
Authors: Gabe B Bleeker; Jeroen J Bax; Jeffrey Wing-Hong Fung; Ernst E van der Wall; Qing Zhang; Martin J Schalij; Joseph Yat-Sun Chan; Cheuk-Man Yu Journal: Am J Cardiol Date: 2005-11-28 Impact factor: 2.778
Authors: Shajil Chalil; Berthold Stegemann; Sarkaw Muhyaldeen; Kayvan Khadjooi; Russell E A Smith; Paul J Jordan; Francisco Leyva Journal: J Am Coll Cardiol Date: 2007-06-29 Impact factor: 24.094
Authors: Patrick A Helm; Laurent Younes; Mirza F Beg; Daniel B Ennis; Christophe Leclercq; Owen P Faris; Elliot McVeigh; David Kass; Michael I Miller; Raimond L Winslow Journal: Circ Res Date: 2005-12-08 Impact factor: 17.367
Authors: André Schmidt; Clerio F Azevedo; Alan Cheng; Sandeep N Gupta; David A Bluemke; Thomas K Foo; Gary Gerstenblith; Robert G Weiss; Eduardo Marbán; Gordon F Tomaselli; João A C Lima; Katherine C Wu Journal: Circulation Date: 2007-03-26 Impact factor: 29.690
Authors: Robert H Helm; Christophe Leclercq; Owen P Faris; Cengizhan Ozturk; Elliot McVeigh; Albert C Lardo; David A Kass Journal: Circulation Date: 2005-05-23 Impact factor: 29.690
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Dominique Auger; Gabe B Bleeker; Matteo Bertini; See H Ewe; Rutger J van Bommel; Tomasz G Witkowski; Arnold C T Ng; Lieselot van Erven; Martin J Schalij; Jeroen J Bax; Victoria Delgado Journal: Eur Heart J Date: 2012-01-24 Impact factor: 29.983
Authors: Kenneth C Bilchick; Sujith Kuruvilla; Yasmin S Hamirani; Raghav Ramachandran; Samantha A Clarke; Katherine M Parker; George J Stukenborg; Pamela Mason; John D Ferguson; J Randall Moorman; Rohit Malhotra; J Michael Mangrum; Andrew E Darby; John Dimarco; Jeffrey W Holmes; Michael Salerno; Christopher M Kramer; Frederick H Epstein Journal: J Am Coll Cardiol Date: 2014-03-05 Impact factor: 24.094
Authors: Daniel R Ludwig; Mati Friehling; Erik B Schelbert; David Schwartzman Journal: Eur J Nucl Med Mol Imaging Date: 2013-11-09 Impact factor: 9.236